RARyan Amini

Ryan Amini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ryan Amini has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Yingfu Li

    Department of Biochemistry and Biomedical Sciences McMaster University Hamilton Ontario Canada

    7 shared publications
  • Jiuxing Li

    Dalian POCT Laboratory Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education) School of Environmental Science and Technology Dalian University of Technology Dalian China

    6 shared publications
  • Zijie Zhang

    School of Environmental Science and Technology, Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), Dalian University of Technology, Dalian POCT Laboratory, Dalian, 116024, China

    6 shared publications
  • Jimmy Gu

    Department of Biochemistry and Biomedical Sciences McMaster University 1280 Main Street West Hamilton Ontario L8S 4K1 Canada

    5 shared publications
  • John David Brennan

    Biointerfaces Institute McMaster University Hamilton Ontario Canada

    5 shared publications
  • Bruno J. Salena

    Department of Medicine McMaster University 1280 Main Street West Hamilton Ontario L8S 4K1 Canada

    3 shared publications

Latest Publications

  • Cover Feature: Aptamers for SARS‐CoV‐2: Isolation, Characterization, and Diagnostic and Therapeutic Developments (Anal. Sens. 5/2022)

    by Ryan Amini, Zijie Zhang, Jiuxing Li, Jimmy Gu, John D. Brennan, Yingfu Li

    The cover feature image shows nucleic acid aptamers armed and ready for our battle against the monstrous SARS‐CoV‐2 virus. Often thought of as “chemical antibodies”, these molecular recognition elements are equipped with several unique benefits and have thus been a popular research subject worldwide. Many aptamers for recognizing the spike and nucleocapsid proteins of SARS‐CoV‐2 have been developed and examined as diagnostic and therapeutic weaponry for the war against COVID‐19 and future pandemics. More information can be found in the Review by J. D. Brennan, Y. Li, and co‐workers.


  • One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS‐CoV‐2

    by Jiuxing Li, Zijie Zhang, Ryan Amini, Yingfu Li

    Aptamers that can recognize the spike (S) protein of SARS‐CoV‐2 with high affinity and specificity are useful molecules towards the development of diagnostics and therapeutics to fight COVID‐19. However, this S protein is constantly mutating, producing variants of concern (VoCs) that can significantly weaken the binding by aptamers initially engineered to recognize the S protein of the wildtype virus or a specific VoC. One strategy to overcome this problem is to develop universal aptamers that are insensitive to all or most of the naturally emerging mutations in the protein. We have recently demonstrated this concept by subjecting a pool of S protein‐binding DNA aptamers for one‐round parallel‐SELEX experiments targeting 5 different S protein variants for binding‐based sequence enrichment, followed by bioinformatic analysis of the enriched pools. This effort has led to the identification of a universal aptamer that recognizes 8 different variants of the spike protein with equally excellent affinity.


  • Aptamers for SARS‐CoV‐2: Isolation, Characterization, and Diagnostic and Therapeutic Developments

    by Ryan Amini, Zijie Zhang, Jiuxing Li, Jimmy Gu, John D. Brennan, Yingfu Li

    The SARS‐CoV‐2 virus and COVID‐19 pandemic continue to demand effective diagnostic and therapeutic solutions. Finding these solutions requires highly functional molecular recognition elements. Nucleic acid aptamers represent a possible solution. Characterized by their high affinity and specificity, aptamers can be rapidly identified from random‐sequence nucleic acid libraries. Over the past two years, many labs around the world have rushed to create diverse aptamers that target two important structural proteins of SARS‐CoV‐2: the spike (S) protein and nucleocapsid (N) protein. These have led to the identification of many aptamers that show real promise for the development of diagnostic tests and therapeutic agents for SARS‐CoV‐2. Herein we review all these developments, with a special focus on the development of diverse aptasensors for detecting SARS‐CoV‐2. These include electrochemical and optical sensors, lateral flow devices, and aptamer‐linked immobilized sorbent assays.


  • A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern

    by Zijie Zhang, Jiuxing Li, Jimmy Gu, Ryan Amini, Hannah D. Stacey, Jann C. Ang, Dawn White, Carlos D. M. Filipe, Karen Mossman, Matthew S. Miller, et al.

    Invited for the cover of this issue are John Brennan, Yingfu Li, and co‐workers at McMaster University. The image depicts MSA52 as a universal DNA aptamer that recognizes spike proteins of diverse SARS‐CoV‐2 variants of concern. Read the full text of the article at 10.1002/chem.202200078.


  • Front Cover: A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern (Chem. Eur. J. 15/2022)

    by Zijie Zhang, Jiuxing Li, Jimmy Gu, Ryan Amini, Hannah D. Stacey, Jann C. Ang, Dawn White, Carlos D. M. Filipe, Karen Mossman, Matthew S. Miller, et al.

    A unique DNA aptamer, denoted MSA52, displays universally high affinity for the spike proteins of the wild‐type SARS‐CoV‐2 as well as its Alpha, Beta, Gamma, Epsilon, Kappa, Delta and Omicron variants. This aptamer also recognizes pseudotyped lentiviruses expressing eight different spike proteins of SARS‐CoV‐2 with very high affinity, exhibiting dissociation constants (K d) of 20–50 pM for these viruses. More information can be found in the Research Article by J. D. Brennan, Y. Li et al. (DOI: 10.1002/chem.202200078).

  • Open Access

    A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern

    by Zijie Zhang, Jiuxing Li, Jimmy Gu, Ryan Amini, Hannah D. Stacey, Jann C. Ang, Dawn White, Carlos D. M. Filipe, Karen Mossman, Matthew S. Miller, et al.

    We report on a unique DNA aptamer, denoted MSA52, that displays universally high affinity for the spike proteins of wildtype SARS‐CoV‐2 as well as the Alpha, Beta, Gamma, Epsilon, Kappa, Delta and Omicron variants. Using an aptamer pool produced from round 13 of selection against the S1 domain of the wildtype spike protein, we carried out one‐round SELEX experiments using five different trimeric spike proteins from variants, followed by high‐throughput sequencing and sequence alignment analysis of aptamers that formed complexes with all proteins. A previously unidentified aptamer, MSA52, showed Kd values ranging from 2 to 10 nM for all variant spike proteins, and also bound similarly to variants not present in the reselection experiments. This aptamer also recognized pseudotyped lentiviruses (PL) expressing eight different spike proteins of SARS‐CoV‐2 with Kd values between 20 and 50 pM, and was integrated into a simple colorimetric assay for detection of multiple PL variants. This discovery provides evidence that aptamers can be generated with high affinity to multiple variants of a single protein, including emerging variants, making it well‐suited for molecular recognition of rapidly evolving targets such as those found in SARS‐CoV‐2.


  • Functional Nucleic Acids Under Unusual Conditions

    by Tianjun Chang, Sisi He, Ryan Amini, Yingfu Li

    Functional nucleic acids (FNAs), including naturally occurring ribozymes and riboswitches as well as artificially created DNAzymes and aptamers, have been popular molecular toolboxes for diverse applications. Given the high chemical stability of nucleic acids and their ability to fold into diverse sequence‐dependent structures, FNAs are suggested to be highly functional under unusual reaction conditions. This review will examine the progress of research on FNAs under conditions of low pH, high temperature, freezing conditions, and the inclusion of organic solvents and denaturants that are known to disrupt nucleic acid structures. The FNA species to be discussed include ribozymes, riboswitches, G‐quadruplex‐based peroxidase mimicking DNAzymes, RNA‐cleaving DNAzymes, and aptamers. Research within this space has not only revealed the hidden talents of FNAs but has also laid important groundwork for pursuing these intriguing functional macromolecules for unique applications.